Agenus Inc.
- Biotech or pharma, therapeutic R&D
Agenus Inc. (NASDAQ: AGEN)
Agenus is a clinical-stage immuno-oncology with a diverse portfolio of checkpoint antibodies, multi-specifics, cell therapies, vaccines, and adjuvants.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}